Overview

Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa

Status:
Unknown status

Trial end date:
2019-08-01

Target enrollment:

Participant gender:

Summary

This clinical trial is a single-site, 30 patient study for participants who have early stage retinitis pigmentosa, or Usher syndrome (type 2 or 3). Funding Source - FDA OOPD and Foundation Fighting Blindness.

Phase:

Phase 2

Details

Lead Sponsor:

Neurotech Pharmaceuticals

Collaborators:

FDA Office of Orphan Products Development
University of California, San Francisco